An article in the Motley Fool just named two “cheap stocks to buy before the 2020 Election.”
The writer likes Cisco Systems (NASDAQ: CSCO) and Baozun (NASDAQ: BZUN) for the following reasons:
Cisco Systems should see significant tailwinds from trends including the Internet of Things and the rollout of 5G network technologies no matter who wins the election.
Among the points listed on Trump’s official 2020 policy platform is a provision to “win the race to 5G and establish a national high-speed wireless internet network.” Making good on that goal might require closer collaboration between the government and network technology leaders, including Cisco.
Chinese e-commerce has never been hotter, and eMarketer estimates that spending in the category will rise roughly 24% this year to hit $2.4 trillion. However, Baozun’s stock performance over the last couple of years hasn’t reflected the strength of online retail in the country.
A Biden victory in November could reduce the risk of substantial new tariffs and alleviate concerns that Chinese consumers will be less likely to purchase U.S. brands due to rising political tensions between the two countries. Some tensions between the competing economic powers will remain regardless of the election outcome, but Baozun looks like a portfolio addition that could be better positioned to prosper under a Biden administration.
Here is a company that could prove to be very undervalued again, no matter who wins the election.
Take a look at Glucose Health, Inc. (OTC Pink: GLUC). Glucose Health manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®.
Now… more than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report released by the Centers for Disease Control and Prevention (CDC).
Despite being on the shelves of Walmart (NYSE: WMT), CVS Health (NYSE: CVS) and online at Amazon.com (NASDAQ: AMZN), GLUC is still trading below a $30 million valuation.
GLUCODOWN® is infused with a special form of diabetic fiber demonstrated in more than 20 clinical studies to help maintain healthy blood sugar levels and regular digestive health.
See all of their products here;
Glucose Health, Inc. (OTC Pink: GLUC) just announced unprecedented consumer demand and 2nd quarter fiscal 2020 sales. 2nd quarter fiscal 2020 revenues increased 186% compared to the 2nd quarter of fiscal 2019 – in fact, Q2 2020 revenues were just $7,140 short of tripling 2nd quarter 2019 revenues.
What are the revenues of this company going to look like when the latest GLUCODOWN® numbers are reported for Q3 and Q4?
Over the past 12 months, GLUC has seen a range of approximately $.20 – $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetes space and should be on everybody’s watch list.
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.